BIIB Financial Facts

Diluted earnings per share attributable to Biogen Idec Inc.: 238.35M
Amortization of acquired intangible assets: 100M
See Full Income Statement

Intangible assets, net: 4.47B
Other current assets: 226.13M
See Full Balance Sheet

Biogen Idec Inc. (BIIB) Earnings

  |   Expand Research on BIIB
Next EPS Date 4/23/14 EPS Growth Rate +29.9%
Average EPS % Beat Rate +13.8% Revenue Growth Rate +42.9%
Average % Move 1-Wk after EPS -0.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
4/23/14 Q114 N/A$2.56 N/A N/A$2B = N/A N/A
5/1/12 Q112 $1.40$1.48 -$0.08$1.29B$1.31B = +116.8% Details
1/28/13 Q412 $1.40$1.46 -$0.06$1.4B$1.38B +98.7% Details
7/26/11 Q211 $1.36$1.37 -$0.01$1.21B$1.18B = +179.4% Details
4/21/11 Q111 $1.43$1.41 +$0.02$1.2M$1.18B = +235.6% Details
1/31/12 Q411 $1.51$1.49 +$0.02$1.3B$1.29B = +149.2% Details
1/29/14 Q413 $2.34$2.27 +$0.07$2B$1.93B = -4.9% Details
10/28/11 Q311 $1.61$1.53 +$0.08$1.31B$1.27B = +146.8% Details